Please login to the form below
Noveida
This page shows the latest Noveida news and features for those working in and with pharma, biotech and healthcare.
InVentiv Health opens offices in New York and Tokyo
Noveida Health, and will be led by John LaPolla. With degrees in microbiology from Cornell University and in biochemistry from Mount Sinai Medical Center, LaPolla has spent the last 14 years
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Rocky start for Biogen’s Alzheimer’s drug Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
- Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
- US demand for COVID-19 antibody treatments rising fast
- Our mission: helping patients in areas of unmet medical need
- Novo Nordisk settles US insulin pricing dispute for $100m
- Mysterious big pharma company eyes US biotech Acceleron
- COVID-19 changed change and communications will never be the same
- Understanding behaviour change: A Porterhouse Insights specialism
- Lynparza significantly delays disease progression as first-line treatment in prostate cancer
- David Hunt launches independent agency The Considered
- Live Webinar: Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- Lucid Group celebrates a double win at Communiqué 2021
- China backs use of Roche’s Actemra for coronavirus
- Future of MHRA uncertain amid Brexit-fuelled shake up
Latest intelligence
- Understanding behaviour change: A Porterhouse Insights specialism
- ...
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
